CTP-692

CTP-692 · Concert Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CTP-692, covering 2023-12-22 to 2023-12-22. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-692 as an Adjunctive Treatment in Adults With Schizophrenia [Phase 2]

See pricing